A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2001
11/21/2001	CN1323222A LT and CT in parenteral immunization methods against helicobacter infection
11/21/2001	CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1323214A Anionic or cationic dendrimer antimicrobial or antiparasitic composition
11/21/2001	CN1323212A A method of modulating ion channel functional activity
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1322762A Humanized antibody with specificity to HBV surface antigen PRE-S1 and its producing process
11/21/2001	CN1322573A Bone-repairing material preparing method
11/21/2001	CN1322550A Medicine for treating bone tuberculosis
11/21/2001	CN1322540A Phthisis treating Chinese herbal medicine
11/21/2001	CN1322531A Balancing antiinflame agent
11/21/2001	CN1322529A Application of double-stranded ribonucleic acid in preparing medicine for treating human Coxsackie virus infection
11/21/2001	CN1322527A Dysentery treating medicine
11/21/2001	CN1322474A Aggregation-preventing nanometer wide-spectrum antibacterial silve powder and its inductrial production process
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/21/2001	CN1075073C Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
11/21/2001	CN1075064C New benzoxazinedione derivatives, and producing process thereof and use
11/21/2001	CN1075063C Asymmetric synthesis of benzoxazinones compound
11/21/2001	CN1074931C Anti microbial agent for staphylococcus and its use
11/21/2001	CN1074925C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
11/21/2001	CN1074924C Preparing method for medical composition containing 1,3-oxathiolane nucleoside analogues
11/21/2001	CN1074921C Use of N-alkyl derivatives of 1,5-dideoxy-1,5-imino-D-glucitol for the treatment of hepatitis B virus infections
11/21/2001	CN1074898C Ionene polymers, producing process, its intermediate and use
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6320051 Amino(nh) or oxygen(o) substituted, enzyme inhibitors of staphloccocus aureus methionyl t-rna synthetase (mrs); antibacterial agents
11/20/2001	US6320036 GbpA
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319951 Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections
11/20/2001	US6319933 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives; fungicides
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319666 Treating humans for viral infections; incubate human with antigen, monitor immunological response, screen for presence of viral proteins
11/20/2001	US6319509 Pharmaceutical composition
11/20/2001	US6319504 Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
11/20/2001	US6319501 Vaccine comprising hepatitis b virus surface antigen having sequence (ctkpsdgnc) within residues s(139-147) and at least one non-permitted variant of said surface antigen
11/20/2001	CA2217026C New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
11/20/2001	CA2071971C The use of arginine as an immunostimulator
11/15/2001	WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085959A2 Regulation of human lysostaphin-like protease
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085940A2 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS
11/15/2001	WO2001085919A1 Hiv-producing cell line and use thereof
11/15/2001	WO2001085917A2 A device
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085772A2 Virulence genes, proteins, and their use
11/15/2001	WO2001085770A2 Sentinel virus ii
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085751A1 Polymeric compounds useful as prodrugs
11/15/2001	WO2001085750A1 Uridine derivatives as antibiotics
11/15/2001	WO2001085749A1 Anti-viral pyrimidine nucleoside analogues
11/15/2001	WO2001085720A1 Novel anti-infectives
11/15/2001	WO2001085709A2 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
11/15/2001	WO2001085700A2 Hiv replication inhibiting pyrimidines and triazines
11/15/2001	WO2001085699A2 Prodrugs of hiv replication inhibiting pyrimidines
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085684A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	WO2001085256A2 Critical illness neuropathy
11/15/2001	WO2001085209A2 Treating t-cell mediated diseases by modulating dr6 activity
11/15/2001	WO2001085208A2 Molecular antigen arrays and vaccines
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085189A1 Preparation for topically treating manifestations caused by virus infections
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	WO2001085172A1 Novel anti-infectives
11/15/2001	WO2001085170A1 Peptide deformylase inhibitors
11/15/2001	WO2001085164A1 The treatment of herpes
11/15/2001	WO2001085160A1 Peptide deformylase inhibitors
11/15/2001	WO2001085149A2 Felbamate derived compounds
11/15/2001	WO2001085141A1 β-GLUCANS ENCAPSULATED IN LIPOSOMES
11/15/2001	WO2001085116A2 Synergistic antiplaque/antigingivitis oral composition
11/15/2001	WO2001085095A2 Chiral fluoroquinolizinone arginine salt forms
11/15/2001	WO2001076627A8 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
11/15/2001	WO2001038350A3 85kDa NEISSERIAL ANTIGEN
11/15/2001	WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001	WO2001032882A3 Nucleic acids and proteins from group b streptococcus
11/15/2001	WO2001032652A3 N-substituted carbamoyloxyalkyl-azolium derivatives
11/15/2001	WO2001019974A3 Recombinant microorganisms
11/15/2001	WO2001016292A8 37 staphylococcus aureus genes and polypeptides
11/15/2001	WO2001008672A3 Glucamine compounds for treating hepatitis virus infections
11/15/2001	WO2001006756A3 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
11/15/2001	WO2001003717A3 Methods of inducing cell death
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000078344A8 Prion protein peptides and uses thereof
11/15/2001	WO2000054730A3 Compositions preparations and uses of human papillomavirus l1 protein
11/15/2001	US20010041964 Pharmacokinetic-based drug design tool and method
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041691 (Dihydrogen phosphonoxy)alkyloxy containing a triazole derivative used as antifungal agent

1 ... 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 ... 1798